BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 11159196)

  • 1. CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A.
    Schraml P; Struckmann K; Bednar R; Fu W; Gasser T; Wilber K; Kononen J; Sauter G; Mihatsch MJ; Moch H
    Am J Pathol; 2001 Feb; 158(2):593-601. PubMed ID: 11159196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic loss at the D9S171 locus on chromosome 9p13 is associated with progression of papillary renal cell carcinoma.
    Schraml P; Müller D; Bednar R; Gasser T; Sauter G; Mihatsch MJ; Moch H
    J Pathol; 2000 Mar; 190(4):457-61. PubMed ID: 10699995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour suppressor gene (CDKNA2) status on chromosome 9p in resected renal tissue improves prognosis of localised kidney cancer.
    El-Mokadem I; Kidd T; Pratt N; Fleming S; Nabi G
    Oncotarget; 2016 Nov; 7(45):73045-73054. PubMed ID: 27682877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite alteration and immunohistochemical expression profile of chromosome 9p21 in patients with sporadic renal cell carcinoma following surgical resection.
    El-Mokadem I; Lim A; Kidd T; Garret K; Pratt N; Batty D; Fleming S; Nabi G
    BMC Cancer; 2016 Jul; 16():546. PubMed ID: 27465101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
    Pollock PM; Welch J; Hayward NK
    Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu X; An Q; Zhang J; Tang P; Cheng S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of CDKN2A(p16)/CDKN2B(p15) alterations and homozygous chromosome arm 9p deletions in human lung carcinoma.
    Hamada K; Kohno T; Kawanishi M; Ohwada S; Yokota J
    Genes Chromosomes Cancer; 1998 Jul; 22(3):232-40. PubMed ID: 9624535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis.
    Velickovic M; Delahunt B; McIver B; Grebe SK
    Mod Pathol; 2002 May; 15(5):479-85. PubMed ID: 12011252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma.
    Takita J; Hayashi Y; Kohno T; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
    Cancer Res; 1997 Mar; 57(5):907-12. PubMed ID: 9041193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex patterns of chromosome 9 alterations including the p16INK4a locus in Wilms tumours.
    Natrajan R; Warren W; Messahel B; Reis-Filho JS; Brundler MA; Dome JS; Grundy PE; Vujanic G; Pritchard-Jones K; Jones C
    J Clin Pathol; 2008 Jan; 61(1):95-102. PubMed ID: 17369505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent loss of heterozygosity in early non-small cell lung cancers at chromosome 9p21 proximal to the CDKN2a gene.
    Mead LJ; Gillespie MT; Hung JY; Rane US; Rayeroux KC; Irving LB; Campbell LJ
    Int J Cancer; 1997 Apr; 71(2):213-7. PubMed ID: 9139845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population.
    Biden K; Young J; Buttenshaw R; Searle J; Cooksley G; Xu DB; Leggett B
    Hepatology; 1997 Mar; 25(3):593-7. PubMed ID: 9049204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of CDKN2A alterations in esophageal squamous cell carcinoma from a high-risk Chinese population.
    Hu N; Wang C; Su H; Li WJ; Emmert-Buck MR; Li G; Roth MJ; Tang ZZ; Lu N; Giffen C; Albert PS; Taylor PR; Goldstein AM
    Genes Chromosomes Cancer; 2004 Mar; 39(3):205-16. PubMed ID: 14732922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
    Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
    Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
    Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDKN2A is not the principal target of deletions on the short arm of chromosome 9 in neuroendocrine (Merkel cell) carcinoma of the skin.
    Cook AL; Pollock PM; Welch J; Walsh MD; Bowman RV; Baumann KC; Hayward NK; Leonard JH
    Int J Cancer; 2001 Aug; 93(3):361-7. PubMed ID: 11433400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.